Title:Titanium (IV) μ-Oxo Complex Supported by Phenoxyimine Ligand: Synthesis, Crystal Structure Characterisation, DFT and
Molecular Docking Studies
Volume: 21
Issue: 12
Author(s): Vinodkumar P. Sajjan, Prabhuodeyara M. Gurubasavaraj*, Vikram Pujari, Sanjeev R. Inamdar and Nobendu Mukerjee
Affiliation:
- Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical
Sciences, Chennai, India
Keywords:
Titanium complex, phenoxyimine ligand, DFT calculation, docking study, crystalline complex, X-ray.
Abstract:
Background: Most of the transition elements in the 3d series (first row transition metals) have
been discovered to be extremely significant and practical in biological systems. Naturally, many of the
enzymes that are present in the human body system act as catalysts for biological processes and are made
of coordination compounds or complexes.
Objective: The complex has been characterised by various spectroscopic and analytic techniques. A suitable
crystal analysed by X-ray diffraction establishes the formation of a stable binuclear μ-oxo-complex
with a hexacoordinate titanium centre.
Methods: A new crystalline complex [Ti{La}] has been synthesised in the reaction of titanium butoxide
with a phenoxyimine ligand in a 1:1 stoichiometry in toluene at room temperature under a nitrogen atmosphere.
The newly synthesised Ti complex has undergone density functional theory and docking study.
Results: The crystal shows a monoclinic system with space group C 1 2/c 1. X-ray crystal structure analysis
reveals that this complex has a rhomboidal Ti-O-Ti core and exhibits a C2 symmetric conformation
with distorted octahedral geometry. Density Functional Theory (DFT) calculations giving insights into the
frontier orbitals and mulliken charge analysis, which showed good correlation with the experimental findings.
Additionally, in silico molecular docking of ligand and complex was carried out against the HER2
inhibitor kinase.
Conclusion: This complex exhibits a higher binding energy of ΔGb = -19.7 kcal/mol with the active
pocket of HER2 (PDB:7JXH) than the ligand ΔGb = -8.5 kcal/mol.